Olerup Inc presented the extended HLA typing portfolio at this year’s ASHI
At the recently held ASHI meeting in New Orleans, Allenex subsidiary Olerup SSP and Conexio presented the now extended HLA typing portfolio distributed in the US by Olerup Inc. The focus of the symposium was the recently signed global distribution agreement between Conexio and Olerup SSP. Through the agreement Olerup SSP acquired the distribution and marketing rights for the Conexio SBT Resolver™ product line which includes locus specific assays for HLA. Olerup SSP and Olerup Inc. are both part of Allenex Group.
Olerup SSP® and SBT Resolver™ to work hand in hand
“With the inclusion of the SBT Resolver™ product line into our business we now have an excellent product portfolio to further strengthen our presence in the HLA labs. Being a leading supplier to the HLA community and now offering two types of typing techniques gives us possibilities to help both the low- to medium- as well as the high through put HLA typing labs to further enhance HLA typing according to their specific needs”, says Anna Hedlund, Head of R&D at Olerup SSP AB.
The two product lines work perfectly as standalone product lines and will continue to do so also in the future. Moreover, the benefits of combining Olerup SSP®products with SBT Resolver™ kits in daily work will be even more obvious to the users when, within the next year, first introduce SSP kits tailored to resolve ambiguities due to polymorphisms outside of the target areas of the SBT Resolver™. Updating the respective software, Helmberg SCORE™ and Assign™, so that they in the next step they will be fully communicable with each other in order to share data result. The software development is an important next step forward to offer labs to further facilitate their daily work.
Olerup SSP and Conexio will work together to offer a combined SSP and SBT approach to enable the highest resolution HLA typing. Olerup SSP sets will be designed to type for those alleles that are currently outside of the regions sequenced by Conexio’s SBT Resolver assays.
“We are very satisfied with the interest we got from the HLA community at this year’s ASHI meeting. With our extended product portfolio we now can address large groups of HLA typing labs not just in the US but also globally”, says, Anders Karlsson, CEO of Allenex.
For further information, please visit www.olerup-ssp.com or www.olerup.com
For more information please contact:
Anders Karlsson, CEO Allenex AB, tel: +4670-918 0010, email: anders.karlsson@allenex.se
Lars Öqvist, Director Marketing, Absorber AB, tel +46 76276550 email: lars.oqvist@absorber.se
Or visit www.allenex.se
Allenex is a life science company that develops, manufactures, markets and sells high quality products and services that enables for safer transplantations with better results. Allenex is listed on NASDAQ OMX Stockholm Small Cap (ticker: ALNX).